Research Gives Hope to Patients With Rare Vascular Cancer

Cleveland Clinic researchers suggest that their work could lead to breakthroughs in treating other cancers.

An international research effort, led by a Cleveland Clinic doctor, has discovered the specific genetic alteration that is believed to cause a rare, but devastating vascular cancer. Brian Rubin, MD, PhD, of Cleveland Clinics Pathology and Laboratory Medicine Institute and Lerner Research Institute, helped devise an innovative approach to reveal the genetic clues to epithelioid hemangioendothelioma (EHE). The research was published in the Aug. 31 issue of Science Translational Medicine, and was done in collaboration with Cleveland Clinics Taussig Cancer Institute. The findings are also being used to develop a new diagnostic test for this blood vessel disease.
To continue reading this article or issue you must be a paid subscriber. Sign in

Subscribe to Heart Advisor

Get the next year of Heart Advisor for just $20. And access all of our online content - over 2,000 articles - free of charge.
Subscribe today and save 38%. It's like getting 5 months FREE!
Already Subscribed?
Click Here to Sign In | Forgot your password? | Activate Web Access